sustained release

(redirected from Sustained-release)
Also found in: Dictionary, Acronyms, Wikipedia.

sustained release

sustained release

The delivery of a drug from a tablet or other reservoir over many hours or days (instead of minutes or hours), to provide a durable therapeutic effect.
See also: release
References in periodicals archive ?
It should be noted that delayed-release formulations are slightly different from extended- or sustained-release products.
Based on these figures, use of a sustained-release calcium channel blocker was associated with an adjusted 74%-81% reduction in the risk of this serious disease, said Dr.
Another poster presentation at the meeting reported results of two 8-week studies that compared the effects of sustained-release bupropion, sertraline, and placebo on anxiety in depressed patients: 264 patients received bupropion, 225 sertraline, and 233 placebo.
Ask your pharmacist to provide a list of other drugs which, although neither sustained-release nor enteric-coated, should not be crushed because they may irritate the oral mucosa, are extremely bitter, or contain dyes or substances that stain the teeth or mucosa.
Further, attention should be paid to stepped-care approaches to pain management: beginning with less potent peripherally-acting agents, progressing to antidepressants and finally to sustained-release morphine, when appropriate.
Supplements that contain only water-soluble vitamin C or the Bs are not likely to have trouble dissolving, as long as they're not sustained-release.
Somatuline[R] Autogel[R] is an injectable sustained-release formulation containing lanreotide, a somatostatin analogue.
Somatuline([R]) Autogel([R]) is an injectable sustained-release formulation containing lanreotide, a somatostatin analogue.
Ipsen is one of the world leaders in sustained-release delivery systems with two peptides currently marketed, triptorelin (Decapeptyl([R])) and lanreotide (Somatuline([R])and Somatuline([R])Autogel([R])).
The large comparator study of AVINZA once a day versus oxycodone CR(1) twice a day clearly illustrates the advantages of a true once-a-day sustained-release opioid in different parameters of efficacy providing better around the clock pain control which, combined with a comparable safety profile, contribute significantly to overall patient benefit.
A sustained-release solid injectable implant, as used in other recent studies by EpiTan, was used to compare the two methods.
The large comparator study of AVINZA once a day versus oxycodone CR twice a day clearly illustrates the advantages of a true once-a-day sustained-release opioid in different parameters of efficacy which, combined with a comparable safety profile, contribute to overall patient benefit.

Full browser ?